Sakura Leaf

Sakura leaf extract from Prunus serrulata contains caffeoyl glucose as its primary bioactive compound, which inhibits advanced glycation end-products (AGEs) at 10 μg/mL and suppresses inflammatory nitric oxide production in macrophages. The extract demonstrates anti-aging properties by protecting fibroblasts from apoptosis and reducing oxidative damage through its flavonoid and polyphenol content.

Origin & History

Sakura Leaf (Prunus serrulata/Prunus yedoensis) refers to the leaves of the Japanese cherry blossom tree, native to Japan and East Asia. These leaves are traditionally harvested for their unique aromatic and bioactive compounds, offering benefits for skin vitality and metabolic balance.

Historical & Cultural Context

Traditionally revered in Japanese culinary and herbal practices, Sakura Leaf promotes digestion, relaxation, and skin vitality. It symbolizes renewal, beauty, and the transience of life in cultural rituals, deeply embedded in the nation's aesthetic and medicinal heritage.

Health Benefits

- **Promotes skin vitality**: and elasticity by supporting collagen synthesis and reducing oxidative damage.
- **Exhibits anti-inflammatory properties,**: potentially alleviating skin irritation and systemic inflammation.
- **Supports metabolic balance**: by influencing glucose and lipid metabolism.
- **Offers antioxidant protection**: through flavonoids and polyphenols, neutralizing free radicals.
- **Contributes to immune**: resilience by providing essential vitamins and minerals.
- **Aids digestive health**: through dietary fiber and soothing compounds.

How It Works

Caffeoyl glucose, the primary bioactive compound, inhibits advanced glycation end-products (AGEs) formation and suppresses fibroblast apoptosis by reducing caspase activity triggered by glycated collagen. The extract's quercetin glucoside and coumarin compounds contribute to anti-inflammatory effects by inhibiting nitric oxide production in RAW264 macrophages at concentrations of 10-100 μg/mL. Additional flavonoids including cyanidin-3-glucoside provide antioxidant protection through superoxide scavenging and DPPH radical neutralization.

Scientific Research

Preliminary research, including in vitro and animal studies, suggests Sakura Leaf's potential for skin health, antioxidant protection, and metabolic regulation, attributed to its coumarin and flavonoid content. While traditional uses are well-established, human clinical trials on specific health outcomes are still emerging.

Clinical Summary

Current evidence is limited to in vitro studies on isolated cell lines, with no human clinical trials reported. Laboratory studies demonstrate AGE inhibition at 100 μg/mL crude extract concentration and anti-tumor effects in HeLa and A549 cancer cell lines using Gosen-Sakura variety extracts. Antioxidant studies show 34.2% DPPH scavenging activity at 100 μg/mL in methanolic extracts, with total phenolic content measured at 104.30 μM. The evidence strength remains preliminary, requiring human clinical trials to establish therapeutic efficacy and appropriate dosing protocols.

Nutritional Profile

- Minerals: Calcium, Magnesium, Potassium
- Macronutrients: Dietary Fiber
- Phytochemicals: Coumarin, Flavonoids (quercetin, kaempferol), Polyphenols

Preparation & Dosage

- Dried Leaf: 1–2 grams of dried leaf steeped in hot water for 10–15 minutes, up to twice daily, typically as a tea.
- Powdered Form: 500–1000 mg powdered form daily, often in capsules or blended into beverages.

Synergy & Pairings

Role: Polyphenol/antioxidant base
Intention: Cardio & Circulation | Cognition & Focus
Primary Pairings: Ginger (Zingiber officinale); Turmeric (Curcuma longa); Olive Oil; Lemongrass

Safety & Interactions

No specific safety data, adverse events, or drug interactions have been documented in available research studies. The coumarin content may potentially interact with anticoagulant medications, though no quantitative interaction data exists. Traditional use in Japanese confections suggests low acute toxicity, but no LD50 values or human dosing safety parameters have been established. Pregnant and breastfeeding women should avoid use due to insufficient safety data, and patients on blood-thinning medications should consult healthcare providers before use.